Myocardial Mycn is essential for mouse ventricular wall morphogenesis

Developmental Biology

Volumn 373, Issue 1, 2013, Pages 53-63

  Harmelink, Cristina ^a   Peng, Yin ^a   DeBenedittis, Paige ^a   Chen, Hanying ^b   Shou, Weinian ^b   Jiao, Kai ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiogenesis; Heart development; MYCN; Myocardial wall development; Trabeculation

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 10; CELL CYCLE PROTEIN; INHIBITOR OF DIFFERENTIATION 2; NEU DIFFERENTIATION FACTOR; PROTEIN CCND1; PROTEIN CCND2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MYCN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL SIZE; EMBRYO; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; GENE; GENE ACTIVITY; GENE DELETION; GENE FUNCTION; HEART DEVELOPMENT; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE WALL; MORPHOGENESIS; MOUSE; MYCN GENE; MYOCARDIAL DISEASE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOMERE; SIGNAL TRANSDUCTION;

EID: 84870067205     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2012.10.005     Document Type: Article

References (107)

1. Adhikary S., Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 2005, 6:635-645.
2. Ahuja P., Sdek P., MacLellan W.R. Cardiac myocyte cell cycle control in development, disease, and regeneration. Physiol. Rev. 2007, 87:521-544.
3. Azhar M., Schultz J.l.J., Grupp I., Dorn G.W., Meneton P., Molin D.G., Gittenberger-de Groot A.C., Doetschman T. Transforming growth factor beta in cardiovascular development and function. Cytokine Growth Factor Rev. 2003, 14:391-407.
4. Barnett J.V., Desgrosellier J.S. Early events in valvulogenesis: a signaling perspective. Birth Defects Res. C Embryo. Today 2003, 69:58-72.
5. Bhavsar P.K., Dhoot G.K., Cumming D.V., Butler-Browne G.S., Yacoub M.H., Barton P.J. Developmental expression of troponin I isoforms in fetal human heart. FEBS Lett. 1991, 292:5-8.
6. Boluyt M.O., Li Z.B., Loyd A.M., Scalia A.F., Cirrincione G.M., Jackson R.R. The mTOR/p70S6K signal transduction pathway plays a role in cardiac hypertrophy and influences expression of myosin heavy chain genes in vivo. Cardiovasc. Drugs Ther./Sponsored by the International Society of Cardiovascular Pharmacotherapy 2004, 18:257-267.
7. Bouchard C., Dittrich O., Kiermaier A., Dohmann K., Menkel A., Eilers M., Lüscher B. Regulation of cyclin D2 gene expression by the Myc/Max/Mad network: Myc-dependent TRRAP recruitment and histone acetylation at the cyclin D2 promoter. Genes Dev. 2001, 15:2042-2047.
8. Bouchard C., Thieke K., Maier A., Saffrich R., Hanley-Hyde J., Ansorge W., Reed S., Sicinski P., Bartek J., Eilers M. Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J. 1999, 18:5321-5333.
9. Brunner H.G., Winter R.M. Autosomal dominant inheritance of abnormalities of the hands and feet with short palpebral fissures, variable microcephaly with learning disability, and oesophageal/duodenal atresia. J. Med. Genet. 1991, 28:389-394.
10. Büttiker V., Wojtulewicz J., Wilson M. Imperforate anus in Feingold syndrome. Am. J. Med. Genet. 2000, 92:166-169.
11. Cai C.L., Zhou W., Yang L., Bu L., Qyang Y., Zhang X., Li X., Rosenfeld M.G., Chen J., Evans S. T-box genes coordinate regional rates of proliferation and regional specification during cardiogenesis. Development 2005, 132:2475-2487.
12. Carlsson T., Schindler F.R., Höllerhage M., Depboylu C., Arias-Carrión O., Schnurrbusch S., Rösler T.W., Wozny W., Schwall G.P., Groebe K., Oertel W.H., Brundin P., Schrattenholz A., Höglinger G.U. Systemic administration of neuregulin-1Β1 protects dopaminergic neurons in a mouse model of Parkinson's disease. J. Neurochem. 2011, 117:1066-1074.
13. Celli J., van Bokhoven H., Brunner H.G. Feingold syndrome: clinical review and genetic mapping. Am. J. Med. Genet. A 2003, 122A:294-300.
14. Charron J., Malynn B.A., Fisher P., Stewart V., Jeannotte L., Goff S.P., Robertson E.J., Alt F.W. Embryonic lethality in mice homozygous for a targeted disruption of the N-myc gene. Genes Dev. 1992, 6:2248-2257.
15. Chen H., Shi S., Acosta L., Li W., Lu J., Bao S., Chen Z., Yang Z., Schneider M.D., Chien K.R., Conway S.J., Yoder M.C., Haneline L.S., Franco D., Shou W. BMP10 is essential for maintaining cardiac growth during murine cardiogenesis. Development 2004, 131:2219-2231.
16. Chen J.W., Zhou B., Yu Q.C., Shin S.J., Jiao K., Schneider M.D., Baldwin H.S., Bergelson J.M. Cardiomyocyte-specific deletion of the coxsackievirus and adenovirus receptor results in hyperplasia of the embryonic left ventricle and abnormalities of sinuatrial valves. Circ. Res. 2006, 98:923-930.
17. Christoffels V.M., Habets P.E., Franco D., Campione M., de Jong F., Lamers W.H., Bao Z.Z., Palmer S., Biben C., Harvey R.P., Moorman A.F. Chamber formation and morphogenesis in the developing mammalian heart. Dev. Biol. 2000, 223:266-278.
18. Christoffels V.M., Hoogaars W.M., Tessari A., Clout D.E., Moorman A.F., Campione M. T-box transcription factor Tbx2 represses differentiation and formation of the cardiac chambers. Dev. Dyn. 2004, 229:763-770.
19. Clément S., Stouffs M., Bettiol E., Kampf S., Krause K.H., Chaponnier C., Jaconi M. Expression and function of alpha-smooth muscle actin during embryonic-stem-cell-derived cardiomyocyte differentiation. J. Cell Sci. 2007, 120:229-238.
20. Clewes, O., Narytnyk, A., Gillinder, K.R., Loughney, A.D., Murdoch, A.P., Sieber-Blum, M., 2011. Human Epidermal Neural Crest Stem Cells (hEPI-NCSC)-Characterization and Directed Differentiation into Osteocytes and Melanocytes. Stem Cell Rev.
21. Condorelli G., Drusco A., Stassi G., Bellacosa A., Roncarati R., Iaccarino G., Russo M.A., Gu Y., Dalton N., Chung C., Latronico M.V., Napoli C., Sadoshima J., Croce C.M., Ross J. Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc. Nat. Acad. Sci. U.S.A 2002, 99:12333-12338.
22. Crackower M.A., Oudit G.Y., Kozieradzki I., Sarao R., Sun H., Sasaki T., Hirsch E., Suzuki A., Shioi T., Irie-Sasaki J., Sah R., Cheng H.Y., Rybin V.O., Lembo G., Fratta L., Oliveira-dos-Santos A.J., Benovic J.L., Kahn C.R., Izumo S., Steinberg S.F., Wymann M.P., Backx P.H., Penninger J.M. Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 2002, 110:737-749.
23. Délot E.C. Control of endocardial cushion and cardiac valve maturation by BMP signaling pathways. Mol. Genet. Metab. 2003, 80:27-35.
24. Délot E.C., Bahamonde M.E., Zhao M., Lyons K.M. BMP signaling is required for septation of the outflow tract of the mammalian heart. Development 2003, 130:209-220.
25. Desgrosellier J.S., Mundell N.A., McDonnell M.A., Moses H.L., Barnett J.V. Activin receptor-like kinase 2 and Smad6 regulate epithelial-mesenchymal transformation during cardiac valve formation. Dev. Biol. 2005, 280:201-210.
26. Dunwoodie S.L. Combinatorial signaling in the heart orchestrates cardiac induction, lineage specification and chamber formation. Semin. Cell Dev. Biol. 2007, 18:54-66.
27. Evans S.M., Yelon D., Conlon F.L., Kirby M.L. Myocardial lineage development. Circ. Res. 2010, 107:1428-1444.
28. Fentzke R.C., Buck S.H., Patel J.R., Lin H., Wolska B.M., Stojanovic M.O., Martin A.F., Solaro R.J., Moss R.L., Leiden J.M. Impaired cardiomyocyte relaxation and diastolic function in transgenic mice expressing slow skeletal troponin I in the heart. J. Physiol. 517 1999, 143-157. Pt 1.
29. Fingar D.C., Salama S., Tsou C., Harlow E., Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 2002, 16:1472-1487.
30. Fukazawa R., Miller T.A., Kuramochi Y., Frantz S., Kim Y.D., Marchionni M.A., Kelly R.A., Sawyer D.B. Neuregulin-1 protects ventricular myocytes from anthracycline-induced apoptosis via erbB4-dependent activation of PI3-kinase/Akt. J. Mol. Cell. Cardiol. 2003, 35:1473-1479.
31. Gassmann M., Casagranda F., Orioli D., Simon H., Lai C., Klein R., Lemke G. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 1995, 378:390-394.
32. Gaussin V., Morley G.E., Cox L., Zwijsen A., Vance K.M., Emile L., Tian Y., Liu J., Hong C., Myers D., Conway S.J., Depre C., Mishina Y., Behringer R.R., Hanks M.C., Schneider M.D., Huylebroeck D., Fishman G.I., Burch J.B., Vatner S.F. Alk3/Bmpr1a receptor is required for development of the atrioventricular canal into valves and annulus fibrosus. Circ. Res. 2005, 97:219-226.
33. Gaussin V., Van de Putte T., Mishina Y., Hanks M.C., Zwijsen A., Huylebroeck D., Behringer R.R., Schneider M.D. Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3. Proc. Nat. Acad. Sci. U.S. A. 2002, 99:2878-2883.
34. Geneviève D., de Pontual L., Amiel J., Sarnacki S., Lyonnet S. An overview of isolated and syndromic oesophageal atresia. Clin. Genet. 2007, 71:392-399.
35. Grego-Bessa J., Luna-Zurita L., del Monte G., Bolós V., Melgar P., Arandilla A., Garratt A.N., Zang H., Mukouyama Y.S., Chen H., Shou W., Ballestar E., Esteller M., Rojas A., Pérez-Pomares J.M., de la Pompa J.L. Notch signaling is essential for ventricular chamber development. Dev. Cell. 2007, 12:415-429.
36. Hao J., Ho J.N., Lewis J.A., Karim K.A., Daniels R.N., Gentry P.R., Hopkins C.R., Lindsley C.W., Hong C.C. In vivo structure-activity relationship study of dorsomorphin analogues identifies selective VEGF and BMP inhibitors. ACS Chem. Biol. 2010, 5:245-253.
37. Honjo Y., Kniss J., Eisen J.S. Neuregulin-mediated ErbB3 signaling is required for formation of zebrafish dorsal root ganglion neurons. Development 2008, 135:2615-2625.
38. Hossain, S., Takatori, A., Nakamura, Y., Suenaga, Y., Kamijo, T., Nakagawara, A., 2012. NLRR1 Enhances EGF-Mediated MYCN Induction in Neuroblastoma and Accelerates Tumor Growth In Vivo. Cancer Res.
39. Hunkeler N.M., Kullman J., Murphy A.M. Troponin I isoform expression in human heart. Circ. Res. 1991, 69:1409-1414.
40. Hurlin P.J. N-Myc functions in transcription and development. Birth Defects Res. C Embryol. Today 2005, 75:340-352.
41. Ilagan R., Abu-Issa R., Brown D., Yang Y.P., Jiao K., Schwartz R.J., Klingensmith J., Meyers E.N. Fgf8 is required for anterior heart field development. Development 2006, 133:2435-2445.
42. Jiao K., Kulessa H., Tompkins K., Zhou Y., Batts L., Baldwin H.S., Hogan B.L. An essential role of Bmp4 in the atrioventricular septation of the mouse heart. Genes Dev. 2003, 17:2362-2367.
43. Judge D.P., Dietz H.C. Marfan's syndrome. Lancet 2005, 366:1965-1976.
44. Kang S., Chemaly E.R., Hajjar R.J., Lebeche D. Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways. J. Biol. Chem. 2011, 286:18465-18473.
45. Kato K., Kanamori A., Wakamatsu Y., et al. Tissue distribution of N-myc expression in the early organogenesis period of the mouse embryo. Dev. Growth Differ. 1991, 33:29-36.
46. Kenney A.M., Cole M.D., Rowitch D.H. Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 2003, 130:15-28.
47. Kenney A.M., Widlund H.R., Rowitch D.H. Hedgehog and PI-3 kinase signaling converge on Nmyc1 to promote cell cycle progression in cerebellar neuronal precursors. Development 2004, 131:217-228.
48. Kim H.S., Cho J.W., Hidaka K., Morisaki T. Activation of MEK-ERK by heregulin-beta1 promotes the development of cardiomyocytes derived from ES cells. Biochem. Biophys. Res. Commun. 2007, 361:732-738.
49. Klaassen S., Probst S., Oechslin E., Gerull B., Krings G., Schuler P., Greutmann M., Hürlimann D., Yegitbasi M., Pons L., Gramlich M., Drenckhahn J.D., Heuser A., Berger F., Jenni R., Thierfelder L. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation 2008, 117:2893-2901.
50. Knoepfler P.S., Cheng P.F., Eisenman R.N. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 2002, 16:2699-2712.
51. Lai D., Liu X., Forrai A., Wolstein O., Michalicek J., Ahmed I., Garratt A.N., Birchmeier C., Zhou M., Hartley L., Robb L., Feneley M.P., Fatkin D., Harvey R.P. Neuregulin 1 sustains the gene regulatory network in both trabecular and nontrabecular myocardium. Circ. Res. 2010, 107:715-727.
52. Lasorella A., Boldrini R., Dominici C., Donfrancesco A., Yokota Y., Inserra A., Iavarone A. Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma. Cancer Res. 2002, 62:301-306.
53. Lasorella A., Noseda M., Beyna M., Yokota Y., Iavarone A. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature 2000, 407:592-598.
54. Lee K.F., Simon H., Chen H., Bates B., Hung M.C., Hauser C. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 1995, 378:394-398.
55. Li D., Rozen R. Maternal folate deficiency affects proliferation, but not apoptosis, in embryonic mouse heart. J. Nutr. 2006, 136:1774-1778.
56. Loeys B.L., Schwarze U., Holm T., Callewaert B.L., Thomas G.H., Pannu H., De Backer J.F., Oswald G.L., Symoens S., Manouvrier S., Roberts A.E., Faravelli F., Greco M.A., Pyeritz R.E., Milewicz D.M., Coucke P.J., Cameron D.E., Braverman A.C., Byers P.H., De Paepe A.M., Dietz H.C. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N. Engl. J. Med. 2006, 355:788-798.
57. Ma L., Lu M.F., Schwartz R.J., Martin J.F. Bmp2 is essential for cardiac cushion epithelial-mesenchymal transition and myocardial patterning. Development 2005, 132:5601-5611.
58. McFadden D.G., Olson E.N. Heart development: learning from mistakes. Curr. Opin. Genet. Dev. 2002, 12:328-335.
59. Meyer D., Birchmeier C. Multiple essential functions of neuregulin in development. Nature 1995, 378:386-390.
60. Moens C.B., Auerbach A.B., Conlon R.A., Joyner A.L., Rossant J. A targeted mutation reveals a role for N-myc in branching morphogenesis in the embryonic mouse lung. Genes Dev. 1992, 6:691-704.
61. Moens C.B., Stanton B.R., Parada L.F., Rossant J. Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myc locus. Development 1993, 119:485-499.
62. Morkin E. Control of cardiac myosin heavy chain gene expression. Microsc. Res. Tech. 2000, 50:522-531.
63. Moskowitz I.P., Wang J., Peterson M.A., Pu W.T., Mackinnon A.C., Oxburgh L., Chu G.C., Sarkar M., Berul C., Smoot L., Robertson E.J., Schwartz R., Seidman J.G., Seidman C.E. Transcription factor genes Smad4 and Gata4 cooperatively regulate cardiac valve development. [corrected]. Proc. Nat. Acad. Sci. U.S.A. 2011, 108:4006-4011.
64. Okubo T., Knoepfler P.S., Eisenman R.N., Hogan B.L. Nmyc plays an essential role during lung development as a dosage-sensitive regulator of progenitor cell proliferation and differentiation. Development 2005, 132:1363-1374.
65. Olson, A.K., Ledee, D., Iwamoto, K., Kajimoto, M., O'Kelly Priddy, C., Isern, N., Portman, M.A., 2012. C-Myc induced compensated cardiac hypertrophy increases free fatty acid utilization for the citric acid cycle. J. Mol. Cell. Cardiol.
66. Ota S., Zhou Z.Q., Keene D.R., Knoepfler P., Hurlin P.J. Activities of N-Myc in the developing limb link control of skeletal size with digit separation. Development 2007, 134:1583-1592.
67. Park C., Lavine K., Mishina Y., Deng C.X., Ornitz D.M., Choi K. Bone morphogenetic protein receptor 1A signaling is dispensable for hematopoietic development but essential for vessel and atrioventricular endocardial cushion formation. Development 2006, 133:3473-3484.
68. Pereira A.H., Clemente C.F., Cardoso A.C., Theizen T.H., Rocco S.A., Judice C.C., Guido M.C., Pascoal V.D., Lopes-Cendes I., Souza J.R., Franchini K.G. MEF2C silencing attenuates load-induced left ventricular hypertrophy by modulating mTOR/S6K pathway in mice. PLoS One 2009, 4:e8472.
69. Piersall L.D., Dowton S.B., McAlister W.H., Waggoner D.J. Vertebral anomalies in a new family with ODED syndrome. Clin. Genet. 2000, 57:444-448.
70. Pignatelli R.H., McMahon C.J., Dreyer W.J., Denfield S.W., Price J., Belmont J.W., Craigen W.J., Wu J., El Said H., Bezold L.I., Clunie S., Fernbach S., Bowles N.E., Towbin J.A. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation 2003, 108:2672-2678.
71. Rivera-Feliciano J., Tabin C.J. Bmp2 instructs cardiac progenitors to form the heart-valve-inducing field. Dev. Biol. 2006, 295:580-588.
72. Rohrbach S., Muller-Werdan U., Werdan K., Koch S., Gellerich N.F., Holtz J. Apoptosis-modulating interaction of the neuregulin/erbB pathway with anthracyclines in regulating Bcl-xS and Bcl-xL in cardiomyocytes. J. Mol. Cell. Cardiol. 2005, 38:485-493.
73. Safa R.N., Peng X.Y., Pentassuglia L., Lim C.C., Lamparter M., Silverstein C., Walker J., Chen B., Geisberg C., Hatzopoulos A.K., Sawyer D.B. Neuregulin-1Β regulation of embryonic endothelial progenitor cell survival. Am. J. Physiol. Heart Circ. Physiol. 2011, 300:H1311-1319.
74. Sawai S., Shimono A., Wakamatsu Y., Palmes C., Hanaoka K., Kondoh H. Defects of embryonic organogenesis resulting from targeted disruption of the N-myc gene in the mouse. Development 1993, 117:1445-1455.
75. Schramm, A., Koster, J., Marschall, T., Martin, M., Heilmann, M., Fielitz, K., Buchel, G., Barann, M., Esser, D., Rosenstiel, P., Rahmann, S., Eggert, A., Schulte, J.H., 2012. Next-generation RNA sequencing reveals differential expression of MYCN target genes and suggests the mTOR pathway as a promising therapy target in MYCN-amplified neuroblastoma. Int. J. Cancer.
76. Sedmera D., Pexieder T., Vuillemin M., Thompson R.P., Anderson R.H. Developmental patterning of the myocardium. Anat. Rec. 2000, 258:319-337.
77. Shelton E.L., Yutzey K.E. Tbx20 regulation of endocardial cushion cell proliferation and extracellular matrix gene expression. Dev. Biol. 2007, 302:376-388.
78. Shima H., Pende M., Chen Y., Fumagalli S., Thomas G., Kozma S.C. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO J. 1998, 17:6649-6659.
79. Shioi T., Kang P.M., Douglas P.S., Hampe J., Yballe C.M., Lawitts J., Cantley L.C., Izumo S. The conserved phosphoinositide 3-kinase pathway determines heart size in mice. EMBO J. 2000, 19:2537-2548.
80. Song L., Fässler R., Mishina Y., Jiao K., Baldwin H.S. Essential functions of Alk3 during AV cushion morphogenesis in mouse embryonic hearts. Dev. Biol. 2007, 301:276-286.
81. Song L., Yan W., Chen X., Deng C.X., Wang Q., Jiao K. Myocardial smad4 is essential for cardiogenesis in mouse embryos. Circ. Res. 2007, 101:277-285.
82. Song L., Zhao M., Wu B., Zhou B., Wang Q., Jiao K. Cell autonomous requirement of endocardial Smad4 during atrioventricular cushion development in mouse embryos. Dev. Dyn. 2011, 240:211-220.
83. Srivastava D. Building a heart: implications for congenital heart disease. J. Nucl. Cardiol. 2003, 10:63-70.
84. Srivastava D., Olson E.N. A genetic blueprint for cardiac development. Nature 2000, 407:221-226.
85. Stanton B.R., Perkins A.S., Tessarollo L., Sassoon D.A., Parada L.F. Loss of N-myc function results in embryonic lethality and failure of the epithelial component of the embryo to develop. Genes Dev. 1992, 6:2235-2247.
86. Strieder V., Lutz W. Regulation of N-myc expression in development and disease. Cancer Lett. 2002, 180:107-119.
87. Sugi Y., Yamamura H., Okagawa H., Markwald R.R. Bone morphogenetic protein-2 can mediate myocardial regulation of atrioventricular cushion mesenchymal cell formation in mice. Dev. Biol. 2004, 269:505-518.
88. Takano H., Komuro I., Zou Y., Kudoh S., Yamazaki T., Yazaki Y. Activation of p70 S6 protein kinase is necessary for angiotensin II-induced hypertrophy in neonatal rat cardiac myocytes. FEBS Lett. 1996, 379:255-259.
89. van Bokhoven H., Celli J., van Reeuwijk J., Rinne T., Glaudemans B., van Beusekom E., Rieu P., Newbury-Ecob R.A., Chiang C., Brunner H.G. MYCN haploinsufficiency is associated with reduced brain size and intestinal atresias in Feingold syndrome. Nat. Genet. 2005, 37:465-467.
90. Waite K.A., Eng C. From developmental disorder to heritable cancer: it's all in the BMP/TGF-beta family. Nat. Rev. Genet. 2003, 4:763-773.
91. Wang, J., Kobayashi, T., Floc'h, N., Kinkade, C.W., Aytes, A., Dankort, D., Lefebvre, C., Mitrofanova, A., Cardiff, R.D., McMahon, M., Califano, A., Shen, M.M., Abate-Shen, C., 2012. B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer. Cancer Res.
92. Wang J., Sridurongrit S., Dudas M., Thomas P., Nagy A., Schneider M.D., Epstein J.A., Kaartinen V. Atrioventricular cushion transformation is mediated by ALK2 in the developing mouse heart. Dev. Biol. 2005, 286:299-310.
93. Wang Q., Lin J.L., Reinking B.E., Feng H.Z., Chan F.C., Lin C.I., Jin J.P., Gustafson-Wagner E.A., Scholz T.D., Yang B., Lin J.J. Essential roles of an intercalated disc protein, mXinbeta, in postnatal heart growth and survival. Circ. Res. 2010, 106:1468-1478.
94. Wang Q., Reiter R.S., Huang Q.Q., Jin J.P., Lin J.J. Comparative studies on the expression patterns of three troponin T genes during mouse development. Anat. Rec. 2001, 263:72-84.
95. Wang Q., Sigmund C.D., Lin J.J. Identification of cis elements in the cardiac troponin T gene conferring specific expression in cardiac muscle of transgenic mice. Circ. Res. 2000, 86:478-484.
96. Ward P.S., Thompson C.B. Signaling in control of cell growth and metabolism. Cold Spring Harbor Perspect. Biol. 2012, 4.
97. Weiford B.C., Subbarao V.D., Mulhern K.M. Noncompaction of the ventricular myocardium. Circulation 2004, 109:2965-2971.
98. Westfall M.V., Metzger J.M. Troponin I isoforms and chimeras: tuning the molecular switch of cardiac contraction. News Physiol. Sci. 2001, 16:278-281.
99. Westfall M.V., Turner I., Albayya F.P., Metzger J.M. Troponin I chimera analysis of the cardiac myofilament tension response to protein kinase A. American journal of physiology. Cell physiol. 2001, 280:C324-332.
100. Wiley D.M., Kim J.D., Hao J., Hong C.C., Bautch V.L., Jin S.W. Distinct signalling pathways regulate sprouting angiogenesis from the dorsal aorta and the axial vein. Nat. Cell. Biol. 2011, 13:686-692.
101. Wolfram J.A., Lesnefsky E.J., Hoit B.D., Smith M.A., Lee H.G. Therapeutic potential of c-Myc inhibition in the treatment of hypertrophic cardiomyopathy. Ther. Adv. Chronic Dis. 2011, 2:133-144.
102. Xiao G., Mao S., Baumgarten G., Serrano J., Jordan M.C., Roos K.P., Fishbein M.C., MacLellan W.R. Inducible activation of c-Myc in adult myocardium in vivo provokes cardiac myocyte hypertrophy and reactivation of DNA synthesis. Circ. Res. 2001, 89:1122-1129.
103. Xing Y., Ichida F., Matsuoka T., Isobe T., Ikemoto Y., Higaki T., Tsuji T., Haneda N., Kuwabara A., Chen R., Futatani T., Tsubata S., Watanabe S., Watanabe K., Hirono K., Uese K., Miyawaki T., Bowles K.R., Bowles N.E., Towbin J.A. Genetic analysis in patients with left ventricular noncompaction and evidence for genetic heterogeneity. Mol. Genet. Metab. 2006, 88:71-77.
104. Yang X., Li C., Herrera P.L., Deng C.X. Generation of Smad4/Dpc4 conditional knockout mice. Genesis 2002, 32:80-81.
105. Young P., Nie J., Wang X., McGlade C.J., Rich M.M., Feng G. LNX1 is a perisynaptic Schwann cell specific E3 ubiquitin ligase that interacts with ErbB2. Mol. Cell. Neurosci. 2005, 30:238-248.
106. Zaffran S., Frasch M. Early signals in cardiac development. Circ. Res. 2002, 91:457-469.
107. Zhang W., Chen H., Wang Y., Yong W., Zhu W., Liu Y., Wagner G.R., Payne R.M., Field L.J., Xin H., Cai C.L., Shou W. Tbx20 transcription factor is a downstream mediator for bone morphogenetic protein-10 in regulating cardiac ventricular wall development and function. J. Biol. Chem. 2011, 286:36820-36829.